BeStock  
Stocks › Biotechnology › PTCT

PTC Therapeutics PTCT

US equityMarket cap rank #2094Biotechnology
$56.42 −$1.91 (-3.27%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $56.99 +1.01%
Open$58.78
Prev close$58.33
Day range$56.18 – $58.96
Volume952.6K
Market cap$4.71B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-47.7x
CheapRich

Near the bottom of its 5-year range · 6th percentile, 5-year average -9.7x

Price / book-27.7x
CheapRich

Below its usual level · 20th percentile, 5-year average 61.0x

Price / sales4.6x
CheapRich

Above its usual level · 64th percentile, 5-year average 4.1x

#3831 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-133x-80x-27x27xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$54.23
Price vs. fair value+4.0%Close to the estimate
Star rating★★☆☆☆
Economic moatNarrow
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB -27.74 – 61.04 20% (cheaper than usual) –
PE -47.74 33.62 -9.74 6% (cheaper than usual) –
PS 4.59 3.94 4.05 64% (pricier than usual) #3831 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on PTCT.

Sign in to join the discussion.

Scroll to Top